Literature DB >> 21128751

Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Payal K Naik1, Bethany B Moore.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown origin and progression that primarily affects older adults. Accumulating clinical and experimental evidence suggests that viral infections may play a role, either as agents that predispose the lung to fibrosis or exacerbate existing fibrosis. In particular, herpesviruses have been linked with IPF. This article summarizes the evidence for and against viral cofactors in IPF pathogenesis. In addition, we review mechanistic studies in animal models that highlight the fibrotic potential of viral infection, and explore the different mechanisms that might be responsible. We also review early evidence to suggest that the aged lung may be particularly susceptible to viral-induced fibrosis and make recommendations for future research directions.

Entities:  

Mesh:

Year:  2010        PMID: 21128751      PMCID: PMC3028433          DOI: 10.1586/ers.10.73

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  101 in total

1.  Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C.

Authors:  Ramazan Idilman; Hülya Cetinkaya; Ismail Savaş; Nuray Aslan; Serpil Dizbay Sak; Mehmet Baştemir; Mustafa Sarioğlu; Irfan Soykan; Mithat Bozdayi; Alessandra Colantoni; Olcay Aydintuğ; Kadir Bahar; Ozden Uzunalimoğlu; David H Van Thiel; Numan Numanoğlu; Abdulkadir Dökmeci
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

2.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

3.  Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms.

Authors:  A Diaz; S A Jiménez
Journal:  Int J Biochem Cell Biol       Date:  1997-01       Impact factor: 5.085

Review 4.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

5.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Fernando J Martinez; Lyrica X Liu; Susan Murray; Meilan K Han; Ella A Kazerooni; Barry H Gross; Jeffrey Myers; William D Travis; Thomas V Colby; Galen B Toews; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

6.  Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice.

Authors:  S S Lok; Y Haider; D Howell; J P Stewart; P S Hasleton; J J Egan
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

7.  Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.

Authors:  Katerina Manika; Stella Alexiou-Daniel; Despina Papakosta; Anna Papa; Theodore Kontakiotis; Dimitrios Patakas; Antonis Antoniadis
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2007-09       Impact factor: 0.670

8.  Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.

Authors:  Matthias Schmidt; Guo Sun; Martin A Stacey; Luca Mori; Sabrina Mattoli
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis.

Authors:  Brian G Kelly; She S Lok; Philip S Hasleton; Jim J Egan; James P Stewart
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

10.  Lung epithelial cells are a major site of murine gammaherpesvirus persistence.

Authors:  J P Stewart; E J Usherwood; A Ross; H Dyson; T Nash
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  44 in total

1.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

2.  Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-16       Impact factor: 5.464

Review 3.  Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Harikrishna Tanjore; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

4.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

Review 5.  Cellular senescence in normal and premature lung aging.

Authors:  B Bartling
Journal:  Z Gerontol Geriatr       Date:  2013-10       Impact factor: 1.281

Review 6.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 7.  Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Ivan O Rosas; Paul F Dellaripa; David J Lederer; Dinesh Khanna; Lisa R Young; Fernando J Martinez
Journal:  Ann Am Thorac Soc       Date:  2014-04

8.  PD-1hi CD8+ resident memory T cells balance immunity and fibrotic sequelae.

Authors:  Zheng Wang; Shaohua Wang; Nick P Goplen; Chaofan Li; In Su Cheon; Qigang Dai; Su Huang; Jinjun Shan; Chaoyu Ma; Zhenqing Ye; Min Xiang; Andrew H Limper; Eva-Carmona Porquera; Jacob E Kohlmeier; Mark H Kaplan; Nu Zhang; Aaron J Johnson; Robert Vassallo; Jie Sun
Journal:  Sci Immunol       Date:  2019-06-14

9.  Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.

Authors:  Ying-Ying Liu; Yao Shi; Ya Liu; Xing-Hua Pan; Ke-Xiong Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-06-20       Impact factor: 6.150

10.  Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.

Authors:  Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum
Journal:  J Pharmacol Exp Ther       Date:  2020-11-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.